Guillain-Barré Syndrome

Mayo Clinic Proceedings

Volumn 92, Issue 3, 2017, Pages 467-479

  Wijdicks, Eelco F M ^a   Klein, Christopher J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; HEPARIN; IMMUNOGLOBULIN; INFLUENZA VACCINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTIFICIAL VENTILATION; BREATHING MECHANICS; CELLULAR IMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DYSAUTONOMIA; GUILLAIN BARRE SYNDROME; HUMAN; IMMOBILIZATION; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION RISK; INFLUENZA; INTENSIVE CARE UNIT; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LABORATORY TEST; MULTICENTER STUDY (TOPIC); MUSCLE CRAMP; MYALGIA; NERVE INJURY; NEUROREHABILITATION; NURSING CARE; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; PHYSIOTHERAPY; PLASMA EXCHANGE; PREVENTIVE MEDICINE; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; SYSTEMATIC REVIEW (TOPIC); BACTERIAL INFECTION; CEREBROSPINAL FLUID; COMPLICATION; ECONOMICS; GUILLAIN-BARRE SYNDROME; HISTORY; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; PATHOPHYSIOLOGY; PROCEDURES; VIRUS INFECTION; ZIKA FEVER;

ADMINISTRATION, INTRAVENOUS; BACTERIAL INFECTIONS; CEREBROSPINAL FLUID; CRITICAL CARE; DIAGNOSIS, DIFFERENTIAL; GUILLAIN-BARRE SYNDROME; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOGLOBULINS; PLASMA EXCHANGE; VIRUS DISEASES; ZIKA VIRUS INFECTION;

EID: 85014069091     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2016.12.002     Document Type: Review

References (89)

1. 1 Guillain, G., Barré, J.A., Strohl, A., Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des reflexes tendineux. Bull Memoires Soc Med Hopitaux Paris 40 (1916), 1462–1470.
2. 2 Willison, H.J., Goodfellow, J.A., GBS100: Celebrating a century of progress in Guillain-Barré syndrome. 2016, Peripheral Nerve Society, La Jolla, CA.
3. 3 Saiz, J.C., Vázquez-Calvo, Á., Blázquez, A.B., Merino-Ramos, T., Escribano-Romero, E., Martín-Acebes, M.A., Zika virus: the latest newcomer. Front Microbiol, 7, 2016, 496.
4. 4 Mahecha MP, Ojeda E, Vega DA, Sarmiento-Monroy JC, Anaya JM. Guillain-Barré syndrome in Colombia: where do we stand now [published online ahead of print July 15, 2016]? Immunol Res. http://dx.doi.org/10.1007/s12026-016-8816-8.
5. 5 Broutet, N., Krauer, F., Riesen, M., et al. Zika virus as a cause of neurologic disorders. N Engl J Med 374:16 (2016), 1506–1509.
6. 6 Rogoff, J.B., Pronunciation of Dr Georges Guillain's name. JAMA, 237(23), 1977, 2470.
7. 7 Landry, O., Note sur la paralysie ascendante aiguē. Gaz Hebd Med 6 (1859), 472–474.
8. 8 Wijdicks, E.F.M., Ropper, A.H., The Guillain-Barre syndrome. Koehler, P.J., Bruyn, G.W., Pearce, J.M.S., (eds.) Neurological Eponyms, 2000, Oxford University Press, New York, NY, 219–226.
9. 9 Haymaker, W.E., Kernohan, J.W., The Landry-Guillain-Barré syndrome: a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore) 28:1 (1949), 59–141.
10. 10 Wiederholt, W.C., Mulder, D.W., Lambert, E.H., The Landry-Guillain-Barr'e-Strohl syndrome or polyradiculoneuropathy: historical review, report on 97 patients, and present concepts. Mayo Clin Proc 39 (1964), 427–451.
11. 11 Kurland, L.T., Wiederholt, W.C., Kirkpatrick, J.W., Potter, H.G., Armstrong, P., Swine influenza vaccine and Guillain-Barré syndrome: epidemic or artifact?. Arch Neurol 42:11 (1985), 1089–1090.
12. 12 Feasby, T.E., Gilbert, J.J., Brown, W.F., et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 109:pt 6 (1986), 1115–1126.
13. 13 McKhann, G.M., Cornblath, D.R., Griffin, J.W., et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:4 (1993), 333–342.
14. 14 Ho, T.W., Mishu, B., Li, C.Y., et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:pt 3 (1995), 597–605.
15. 15 Griffin, J.W., Li, C.Y., Ho, T.W., et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 118:pt 3 (1995), 577–595.
16. 16 Griffin, J.W., Li, C.Y., Ho, T.W., et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 39:1 (1996), 17–28.
17. 17 Yuki, N., Yoshino, H., Sato, S., Miyatake, T., Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40:12 (1990), 1900–1902.
18. 18 Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35:8 (1985), 1096–1104.
19. 19 van der Meché, F.G., Schmitz, P.I., Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 326:17 (1992), 1123–1129.
20. 20 Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 349:9047 (1997), 225–230.
21. 21 Hughes, R.A., Wijdicks, E.F., Barohn, R., et al. Practice parameter: immunotherapy for Guillain-Barre syndrome; report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 61:6 (2003), 736–740.
22. 22 Ropper, A.H., Wijdicks, E.F.M., Truax, B.T., Guillain-Barré Syndrome. 1991, FA Davis, Philadelphia, PA.
23. 23 Jacobs, B.C., Rothbarth, P.H., van der Meché, F.G., et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51:4 (1998), 1110–1115.
24. 24 McCarthy, N., Andersson, Y., Jormanainen, V., Gustavsson, O., Giesecke, J., The risk of Guillain-Barré syndrome following infection with. Campylobacter jejuni Epidemiol Infect 122:1 (1999), 15–17.
25. 25 Mori, M., Kuwabara, S., Miyake, M., et al. Haemophilus influenzae infection and Guillain-Barré syndrome. Brain 123:pt 10 (2000), 2171–2178.
26. 26 Rees, J.H., Soudain, S.E., Gregson, N.A., Hughes, R.A., Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333:21 (1995), 1374–1379.
27. 27 Lasky, T., Terracciano, G.J., Magder, L., et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 339:25 (1998), 1797–1802.
28. 28 Poland, G.A., Jacobsen, S.J., Influenza vaccine, Guillain-Barré syndrome, and chasing zero. Vaccine 30:40 (2012), 5801–5803.
29. 29 Salmon, D.A., Proschan, M., Forshee, R., et al., H1N1 GBS Meta-Analysis Working Group. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 381:9876 (2013), 1461–1468.
30. 30 Nagarajan E, Rubin M, Wijdicks EFM, et al. Guillain-Barré syndrome after surgical procedures: predisposing factors and outcome. Neurol Clin Pract in revision.
31. 31 Yuki, N., Molecular mimicry and Guillain-Barré syndrome. [in Japanese] Brain Nerve 67:11 (2015), 1341–1346.
32. 32 Islam, Z., Jacobs, B.C., van Belkum, A., et al. Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology 74:7 (2010), 581–587.
33. 33 Ogawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M., Yuki, N., Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:4 (2000), 624–631.
34. 34 Yuki, N., Susuki, K., Koga, M., et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci U S A 101:31 (2004), 11404–11409.
35. 35 Yuki, N., Taki, T., Inagaki, F., et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 178:5 (1993), 1771–1775.
36. 36 Chiba, A., Kusunoki, S., Shimizu, T., Kanazawa, I., Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 31:6 (1992), 677–679.
37. 37 Fisher, M., An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:2 (1956), 57–65.
38. 38 Phillips, M.S., Stewart, S., Anderson, J.R., Neuropathological findings in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 47:5 (1984), 492–495.
39. 39 Ropper, A.H., Miller Fisher syndrome and other acute variants of Guillain-Barré syndrome. Baillieres Clin Neurol 3:1 (1994), 95–106.
40. 40 Yuan, C.L., Wang, Y.J., Tsai, C.P., Miller Fisher syndrome: a hospital-based retrospective study. Eur Neurol 44:2 (2000), 79–85.
41. 41 Ropper, A.H., Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol 43:11 (1986), 1150–1152.
42. 42 van den Berg, B., Fokke, C., Drenthen, J., van Doorn, P.A., Jacobs, B.C., Paraparetic Guillain-Barré syndrome. Neurology 82:22 (2014), 1984–1989.
43. 43 Bolton, C.F., Chen, R., Wijdicks, E.F.M., Zifco, U.A., Neurology of Breathing. 2004, Elsevier, Amsterdam, the Netherlands.
44. 44 Derenne, J.P., Macklem, P.T., Roussos, C., The respiratory muscles: mechanics, control, and pathophysiology. Am Rev Respir Dis 118:1 (1978), 119–133.
45. 45 Derenne, J.P., Macklem, P.T., Roussos, C., The respiratory muscles: mechanics, control, and pathophysiology; part 2. Am Rev Respir Dis 118:2 (1978), 373–390.
46. 46 Derenne, J.P., Macklem, P.T., Roussos, C., The respiratory muscles: mechanics, control, and pathophysiology; part III. Am Rev Respir Dis 118:3 (1978), 581–601.
47. 47 Laghi, F., Tobin, M.J., Disorders of the respiratory muscles. Am J Respir Crit Care Med 168:1 (2003), 10–48.
48. 48 Burns, T.M., Lawn, N.D., Low, P.A., Camilleri, M., Wijdicks, E.F., Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve 24:7 (2001), 963–965.
49. 49 Emmons, P.R., Blume, W.T., DuShane, J.W., Cardiac monitoring and demand pacemaker in Guillain-Barré syndrome. Arch Neurol 32:1 (1975), 59–61.
50. 50 Flachenecker, P., Hartung, H.P., Reiners, K., Power spectrum analysis of heart rate variability in Guillain-Barré syndrome: a longitudinal study. Brain 120:pt 10 (1997), 1885–1894.
51. 51 Flachenecker, P., Lem, K., Müllges, W., Reiners, K., Detection of serious bradyarrhythmias in Guillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum. Clin Auton Res 10:4 (2000), 185–191.
52. 52 Fugate, J.E., Wijdicks, E.F., Kumar, G., Rabinstein, A.A., One thing leads to another: GBS complicated by PRES and Takotsubo cardiomyopathy. Neurocrit Care 11:3 (2009), 395–397.
53. 53 Lichtenfeld, P., Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 50:6 (1971), 772–780.
54. 54 Mitchell, P.L., Meilman, E., The mechanism of hypertension in the Guillain-Barré syndrome. Am J Med 42:6 (1967), 986–995.
55. 55 Nowe, T., Hüttemann, K., Engelhorn, T., Schellinger, P.D., Köhrmann, M., Paralytic ileus as a presenting symptom of Guillain-Barré syndrome. J Neurol 255:5 (2008), 756–757.
56. 56 Ropper, A.H., Wijdicks, E.F., Blood pressure fluctuations in the dysautonomia of Guillain-Barré syndrome. Arch Neurol 47:6 (1990), 706–708.
57. 57 Truax, B.T., Autonomic disturbances in the Guillain-Barré syndrome. Semin Neurol 4:4 (1984), 462–468.
58. 58 Zochodne, D.W., Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 17:10 (1994), 1145–1155.
59. 59 Hughes, R.A., Cornblath, D.R., Guillain-Barré syndrome. Lancet 366:9497 (2005), 1653–1666.
60. 60 Ruts, L., Drenthen, J., Jacobs, B.C., van Doorn, P.A., Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 74:21 (2010), 1680–1686.
61. 61 Brown, W.F., Feasby, T.E., Conduction block and denervation in Guillain-Barré polyneuropathy. Brain 107:pt 1 (1984), 219–239.
62. 62 Cornblath, D.R., Electrophysiology in Guillain-Barré syndrome. Ann Neurol 27:suppl (1990), S17–S20.
63. 63 Gordon, P.H., Wilbourn, A.J., Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 58:6 (2001), 913–917.
64. 64 McLeod, J.G., Electrophysiological studies in the Guillain-Barré syndrome. Ann Neurol 9:suppl (1981), 20–27.
65. 65 Ropper, A.H., Wijdicks, E.F., Shahani, B.T., Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome. Arch Neurol 47:8 (1990), 881–887.
66. 66 Brettle, R.P., Gross, M., Legg, N.J., Lockwood, M., Pallis, C., Treatment of acute polyneuropathy by plasma exchange. Lancet, 2(8099), 1978, 1100.
67. 67 Raphaël, J.C., Chevret, S., Hughes, R.A., Annane, D., Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev(7), 2012, CD001798.
68. 68 Hughes, R.A., Swan, A.V., van Doorn, P.A., Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev(9), 2014, CD002063.
69. 69 van Doorn, P.A., Ruts, L., Jacobs, B.C., Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7:10 (2008), 939–950.
70. 70 van Koningsveld, R., Schmitz, P.I., Meché, F.G., Visser, L.H., Meulstee, J., van Doorn, P.A., Dutch GBS Study Group. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet 363:9404 (2004), 192–196.
71. 71 Winters, J.L., Brown, D., Hazard, E., Chainani, A., Andrzejewski, C. Jr., Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome. BMC Health Serv Res, 11, 2011, 101.
72. 72 Lawn, N.D., Fletcher, D.D., Henderson, R.D., Wolter, T.D., Wijdicks, E.F., Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol 58:6 (2001), 893–898.
73. 73 Walgaard, C., Lingsma, H.F., Ruts, L., et al. Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol 67:6 (2010), 781–787.
74. 74 Galtrey, C.M., Faulkner, M., Wren, D.R., How it feels to experience three different causes of respiratory failure. Pract Neurol 12:1 (2012), 49–54.
75. 75 Wijdicks, E.F.M., Short of breath, short of air, short of mechanics. Pract Neurol 2 (2002), 208–213.
76. 76 Ali, M.I., Fernández-Pérez, E.R., Pendem, S., Brown, D.R., Wijdicks, E.F., Gajic, O., Mechanical ventilation in patients with Guillain-Barré syndrome. Respir Care 51:12 (2006), 1403–1407.
77. 77 Lawn, N.D., Wijdicks, E.F., Tracheostomy in Guillain-Barré syndrome. Muscle Nerve 22:8 (1999), 1058–1062.
78. 78 Walgaard, C., Lingsma, H.F., van Doorn, P.A., van der Jagt, M., Steyerberg, E.W., Jacobs, B.C., Tracheostomy or not: prediction of prolonged mechanical ventilation in Guillain-Barré syndrome [published online ahead of print August 18, 2016]. Neurocrit Care 26:1 (2017), 6–13.
79. 79 Griggs, R.C., Donohoe, K.M., Utell, M.J., Goldblatt, D., Moxley, R.T. III, Evaluation of pulmonary function in neuromuscular disease. Arch Neurol 38:1 (1981), 9–12.
80. 80 Kramer, C.L., McCullough, M., Wijdicks, E.F., Teaching video neuroimages: how to unmask respiratory strength confounded by facial diplegia. Neurology 84:8 (2015), e57–e58.
81. 81 Wijdicks, E.F.M., Guillain-Barre syndrome. Neurocrit Care 25:2 (2016), 288–292.
82. 82 Fletcher, D.D., Lawn, N.D., Wolter, T.D., Wijdicks, E.F., Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurology 54:12 (2000), 2311–2315.
83. 83 Bernsen, R.A., de Jager, A.E., Schmitz, P.I., van der Meché, F.G., Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome. Neurology 53:2 (1999), 409–410.
84. 84 Baxter, R., Lewis, N., Bakshi, N., et al. Recurrent Guillain-Barré syndrome following vaccination. Clinical Infectious Diseases 54:6 (2012), 800–804.
85. 85 Grohskopf, L.A., Sokolow, L.Z., Broder, K.R., et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 65:5 (2016), 1–54.
86. 86 Wijdicks, E.F., Fletcher, D.D., Lawn, N.D., Influenza vaccine and the risk of relapse of Guillain-Barré syndrome. Neurology 55:3 (2000), 452–453.
87. 87 Cao-Lormeau, V.M., Blake, A., Mons, S., et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387:10027 (2016), 1531–1539.
88. 88 Davidson, A.I., Halstead, S.K., Goodfellow, J.A., et al. Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS Study. J Peripher Nerv Syst, 2016 Nov 1 [Epub ahead of print].
89. 89 Yamaguchi, N., Misawa, S., Sato, Y., et al. A prospective, multicenter, randomized phase II study to evaluate the efficacy and safety of eculizumab in patients with Guillain-Barré syndrome (GBS): protocol of Japanese eculizumab trial for GBS (JET-GBS). JMIR Res Protoc, 5(4), 2016, e210.